GCO Earnings
Latest Revenue529.9M
Latest Net Income3.5M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2027 | $0.33 | 529.9M | 3.5M | -14.0% | -36.5% |
| Q1 2027 | -$1.42 | 487.0M | -14814000 | -21.0% | -373.1% |
| Q4 2026 | $4.60 | 799.9M | 47.6M | +46.5% | +357.0% |
| Q4 2026 | $4.60 | 799.9M | 47.6M | +46.5% | +357.0% |
| Q3 2026 | $0.52 | 616.2M | 5.4M | +30.0% | +125.7% |
| Q3 2026 | $0.52 | 616.2M | 5.4M | +30.0% | +125.7% |
| Q2 2026 | -$1.79 | 546.0M | -18471000 | -26.8% | -155.9% |
| Q2 2026 | -$1.79 | 546.0M | -18471000 | -8.4% | -1.7% |
| Q1 2026 | -$2.02 | 474.0M | -21227000 | — | — |
| Q1 2026 | -$2.02 | 474.0M | -21227000 | — | — |
| Q4 2025 | $3.20 | 745.9M | 34.4M | — | — |
| Q3 2025 | -$1.76 | 596.3M | -18932000 | — | — |
Genes (GCO) — Earnings